Paper6800533
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
Wenting GJ and 4 others. Br Med J (Clin Res Ed), 1982. Cited by 133 papers, by iCite.
Cite this record
ConductScience Library. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Papers, record 6800533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6800533
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Piperidines | Major topic |
| Receptors, Serotonin | Major topic |
| Adult | |
| Aged | |
| Cardiac Output | |
| Female | |
| Heart Rate | |
| Humans | |
| Ketanserin | |
| Kidney | |
| Male | |
| Middle Aged | |
| Norepinephrine | |
| Vascular Resistance |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5411466 | Abnormal renal haemodynamics and renin suppression in hypertensive patients. | Clin Sci | 1970 | https://conductscience.org/library/papers/5411466 | PubMed |
| 2 | 1128155 | A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. | Life Sci | 1975 | https://conductscience.org/library/papers/1128155 | PubMed |
| 3 | 74464 | Inactive renin in human plasma. | Lancet | 1976 | https://conductscience.org/library/papers/74464 | PubMed |
| 4 | 530254 | Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. | Mol Pharmacol | 1979 | https://conductscience.org/library/papers/530254 | PubMed |
| 5 | 6446522 | Review of the role of the central serotonergic neuronal system in blood pressure regulation. | Hypertension | 1980 | https://conductscience.org/library/papers/6446522 | PubMed |
| 6 | 7400317 | Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism. | J Clin Invest | 1980 | https://conductscience.org/library/papers/7400317 | PubMed |
| 7 | 6261070 | Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. | Life Sci | 1981 | https://conductscience.org/library/papers/6261070 | PubMed |
| 8 | 6112515 | Acute blood-pressure-lowering effect of ketanserin. | Lancet | 1981 | https://conductscience.org/library/papers/6112515 | PubMed |
| 9 | 6112531 | 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study. | Lancet | 1981 | https://conductscience.org/library/papers/6112531 | PubMed |
| 10 | 6113280 | Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. | J Pharmacol Exp Ther | 1981 | https://conductscience.org/library/papers/6113280 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 133 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41379296 | Pharmacological effect of quinazoline-2,4(1H,3H)-dione derivatives: a review. | Mol Divers | 2026 | https://conductscience.org/library/papers/41379296 | PubMed |
| 22407614 | Serotonin and blood pressure regulation. | Pharmacol Rev | 2012 | https://conductscience.org/library/papers/22407614 | PubMed |
| 20433685 | 5-hydroxtryptamine receptors in systemic hypertension: an arterial focus. | Cardiovasc Ther | 2011 | https://conductscience.org/library/papers/20433685 | PubMed |
| 6812750 | Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6812750 | PubMed |
| 6712863 | Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6712863 | PubMed |
| 6712862 | Acute effects of ketanserin on left ventricular function, metabolism and coronary blood flow. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6712862 | PubMed |
| 6652362 | Effects of LM 5008, a selective inhibitor of 5-hydroxytryptamine uptake, on blood pressure and responses to sympathomimetic amines. | Br J Pharmacol | 1983 | https://conductscience.org/library/papers/6652362 | PubMed |
| 6628517 | Ketanserin in essential hypertension: effects during rest and exercise. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6628517 | PubMed |
| 6626423 | The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6626423 | PubMed |
| 6617728 | Pharmacokinetics of ketanserin in man. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6617728 | PubMed |
| 6615685 | Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6615685 | PubMed |
| 6432198 | Treatment of Raynaud's phenomenon with ketanserin in patients with connective tissue disorders. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6432198 | PubMed |
| 6362688 | Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension. | Br Heart J | 1984 | https://conductscience.org/library/papers/6362688 | PubMed |
| 6150724 | Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6150724 | PubMed |
| 3801767 | In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists. | Br J Pharmacol | 1986 | https://conductscience.org/library/papers/3801767 | PubMed |
| 3684842 | Profound hypotension after the first dose of ketanserin. | Postgrad Med J | 1987 | https://conductscience.org/library/papers/3684842 | PubMed |
| 3620282 | Lack of effect of ketanserin on indices of hepatic enzyme induction. | Br J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3620282 | PubMed |
| 3595699 | Pharmacokinetics of ketanserin in patients with essential hypertension. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3595699 | PubMed |
| 3240727 | Effect of ketanserin on lipoproteins in patients with essential hypertension. | Drugs | 1988 | https://conductscience.org/library/papers/3240727 | PubMed |
| 3240725 | Effects of ketanserin on systemic and regional haemodynamics in patients with essential hypertension. | Drugs | 1988 | https://conductscience.org/library/papers/3240725 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HTR2A | 3356 | PubTator's text mining | https://conductscience.org/library/genes/3356 | NCBI Gene |
| REN | 5972 | PubTator's text mining | https://conductscience.org/library/genes/5972 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6800533
GET https://conductscience.org/api/papers/v1/6800533/cited_by?page=2